Portal systemic shunting (PSS) and portal pressure were measured in control rats and in animals with portal hypertension induced by partial portal vein ligation (PPVL). The portal pressure in rats with partial portal vein ligation (13.4 + 0.5 mm.Hg.) was significantly higher (p< 0.005) than in the control group (9.6 + 0.6 mm.Hg.). Portal systemic shunting measured by consecutive injections of radiolabelled methylene diphosphonate (MDP), a non-diffusable marker and albumin microspheres directly into the splenic pulp was significantly increased (P < 0.005) in the portal hypertensive animals (30.8 + 2.5%) compared to sham operated rats (2.6 + 1.5%). Simi-larly, in portal hypertensive rats portal systemic shunting measured by intrasplenic injections of radiolabelled cobalt microspheres (37.1 + 3.9%) was significantly greater (p< 0.005) than in control animals. There was a good correlation and agreement (r= 00.97) between the two methods of measuring portal systemic shunting. However because the 99Tcm-albumin microspheres are biodegradable the method allows portal systemic shunting to be measured in man. Furthermore since the computer adjusts the baseline to zero after each determination of portal systemic shunting the methodology allows repeated measurements to be made.
INTRODUCTION
Bleeding from gastro-oesophageal varices is a serious and often fatal complication of portal hypertension in chronic liver disease. Variceal haemorrhage rarely occurs unless the portal pressure exceeds 12 mm Hg1. However, no relationship has been demonstrated between the magnitude of portal pressure and the occurrence of variceal bleeding2. A possible explanation for this observation is the relationship between portal pressure and the blood flow through the collateral circulation including the gastro-oesophageal varices. Thus, although a good correlation has been demon-strated between azygos blood flow (an indirect measurement of collateral blood flow) and portal pressure in man, the relationship is exponential. Thus, when the portal pressure is only mildly elevated above normal in portal hypertensive patients, further relatively large increases in pressure result in only modest elevations in azygos blood flow3. Conversely when the portal pressure is markedly elevated, further small increases in pressure result in large elevations in azygos blood flow3. Furthermore, recent studies have indicated that vasoactive drugs have a differential action on portal pressure and azygos blood flow 4,5. Measurement of collateral blood flow therefore gives information over and above that available from measurements ofportal pressure alone both with respect to the pathophysiology of variceal bleeding and the effects of vasoactive drugs used to control haemorrhage and long-term management of portal hypertension. A reference dose of 15 gl 99mTc-methylene diphosphonate (MDP, 100 MBq/ml) was injected directly into the splenic pulp using a high pressure liquid chromatography (HPLC) syringe. MDP is a low molecular weight non-diffusable marker which is not retained within the liver and consequently all the radioactivity injected passes directly to the lung field of interest. Therefore the increase in count rate after the injection of the MDP was calculated as the difference between the plateau level obtained after its injection and the baseline level and was regarded as the 100% passing fraction (Figure 1 ). The injection ofMDP was followed three minutes later by an intrasplenic injection of the same volume of 99mTc labelled human serum albumin microspheres. In portal hypertensive rats the proportion of albumin microspheres passing to the lungs is proportional to the degree of extrahepatic shunting and was calculated as a percentage ofthe 100% passing fraction ( Figure 1) (Figure 3 ). Figure 5 Relationship of the discrepancy between portal systemic shunting measured by albumin on cobalt microspheres in all rats to the mean PSS by the two techniques.
rats, the data points showed a slight progressive negative bias away from the line of perfect agreement.
However, the majority (40/44) of the data points fell within the limits of agreement (mean difference + 2SD). Therefore there was a good agreement between albumin and cobalt microsphere methods of measuring PSS. In the 10 rats who underwent repeated determinations of PSS, the baseline levels were variable ranging from 17-94% with a median value of 40.5%. The reproducibility of 5 However, the 99Tc-labelled albumin microsphere method allows for repeated measurement of portal systemic shunting in experimental animals. Furthermore since the albumin microspheres are biodegradable this method could also be applied to man. Determination of collateral blood flow in portal hypertensive patients by intrasplenic injection of radiolabelled MDP and albumin microspheres could be used to measure collateral blood flow and portal pressure simultaneously. This would be particularly advantageous in patients with non-alcohol related cirrhosis with a pre-sinusoidal component to their portal hypertension since measurements of corrected wedged hepatic venous pressure (WHVP) do not accurately reflect the portal pressure. There is a risk ofhaemorrhage associated with splenic puncture but this can be over-
